Venkatesh Ramaiah, MD
Vascular Surgery · Scottsdale, AZNPI 1063413904
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $271,280 of the $451,942 with a category attached, or 60.0%. 60 manufacturers reported payments, led by Endologix LLC at 32.7% of the total. Among vascular surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,112 payments — averaging $406.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$148K
- Silk Road Medical, Inc.$102K
- Medtronic$58K
- Shockwave Medical, Inc$39K
- Angiodynamics, Inc.$34K
- Bard Peripheral Vascular, Inc.$14K
- plus $57K from 54 others
Across 81 payments — averaging $2898.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$50K
- Silk Road Medical, Inc.$35K
- Endologix LLC$25K
- Shape Memory Medical Inc.$22K
- Contego Medical, Inc$20K
- Philips North America LLC$16K
- plus $67K from 8 others
What the payments were for
- Consulting fees$271,28060%
- Speaking & faculty fees$61,39014%
- Travel & lodging$71,21416%
- Food & beverage$48,05711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$107,839
- ENROUTE Transcarotid Stent$61,430
- ENHANCE Transcarotid Peripheral Access Kit$57,999
- ENDOCROSS Device$55,562
- Torus Stent Graft System$55,562
- Alto Abdominal Stent Graft System$48,773
- ENROUTE Transcarotid Stent System$39,594
- ENROUTE 0.014 Guidewire$39,594
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$33,151
- Ovation$29,982
- ENROUTE .014 Guidewire$18,405
- Endurant$16,445
- Auryon Laser System 100-120 Vac$13,532
- AFX2 Bifurcated Endograft System$11,603
- ENDURANT IIS$9,884
- AFX$9,020
- Barostim Neo System$8,260
- Valiant Captivia$7,390
- AlphaVac$6,886
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$6,114
How this compares
$451,942 in reported general payments places this provider in the 95th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 56 | $76,315 |
| EliquisApixaban | 14 | $17,201 |
| ClopidogrelClopidogrel Bisulfate | 147 | $2,245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $3,886 | $76,31556 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Scottsdale
- Hasan AldailamiScottsdale$55K
- Herman PangScottsdale$34K
- Mitri KhouryScottsdale$21K
- Andrew MeltzerScottsdale$21K
- Richard RogersScottsdale$13K
- Hara MisraScottsdale$11K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Hammad AmerMesa$169K
- Baljeet UppalSun City$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.